Walbrook PR Appointed By Tissue Regenix Group plc
01 January 2021
Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces its appointment as Financial PR & Investor Relations advisor to AIM listed Tissue Regenix Group plc, the regenerative medical devices company. The team at Walbrook will manage the Company’s communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.